Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta‐analysis

Published:2019-08-19 Issue:9 Volume:49 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Xue Jinru¹,Xin Hua¹,Ren Na¹,Zhou Changyu²,Yang Jinghui³,Song Lina⁴,Qin Shaoyou²^ORCID

Affiliation:

1. Department of Thoracic Surgery China‐Japan Union Hospital of Jilin University Changchun China

2. Department of Gastroenterology and Hepatology China‐Japan Union Hospital of Jilin University Changchun China

3. Department of Hepatobiliary‐Pancreatic Surgery China‐Japan Union Hospital of Jilin University Changchun China

4. Department of Laboratory Medicine Center China‐Japan Union Hospital of Jilin University Changchun China

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13158

Reference40 articles.

1. Non-alcoholic fatty liver disease – A global public health perspective

2. Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

3. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

4. Extrahepatic Diseases and NAFLD: The Triangular Relationship between NAFLD, Type 2-Diabetes and Dysbiosis

5. NAFLD: A multisystem disease

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study;Journal of Gastroenterology and Hepatology;2024-02-29

2. Evaluation of the Effects of Meal Type and Acid‐Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist;Clinical Pharmacology in Drug Development;2024-02-12

3. Evaluation of the effectiveness of the proposed therapy on energy metabolism parameters in patients with chronic liver lesions on the background of secondary immunodeficiency state;Medical Herald of the South of Russia;2023-09-26

4. Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case–control study using a 5-year large-scale claims database;BMJ Open;2023-08

5. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis;Journal of Clinical and Experimental Hepatology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3